annual CFF:
$185.75M+$55.42M(+42.53%)Summary
- As of today (July 27, 2025), NTLA annual cash flow from financing activities is $185.75 million, with the most recent change of +$55.42 million (+42.53%) on December 31, 2024.
- During the last 3 years, NTLA annual CFF has fallen by -$550.94 million (-74.79%).
- NTLA annual CFF is now -74.79% below its all-time high of $736.69 million, reached on December 31, 2021.
Performance
NTLA Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$0.00-$2.32M(-100.00%)Summary
- As of today (July 27, 2025), NTLA quarterly cash flow from financing activities is $0.00, with the most recent change of -$2.32 million (-100.00%) on March 31, 2025.
- Over the past year, NTLA quarterly CFF has dropped by -$59.99 million (-100.00%).
- NTLA quarterly CFF is now -100.00% below its all-time high of $668.68 million, reached on September 30, 2021.
Performance
NTLA quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$125.75M-$59.99M(-32.30%)Summary
- As of today (July 27, 2025), NTLA TTM cash flow from financing activities is $125.75 million, with the most recent change of -$59.99 million (-32.30%) on March 31, 2025.
- Over the past year, NTLA TTM CFF has dropped by -$62.34 million (-33.14%).
- NTLA TTM CFF is now -87.02% below its all-time high of $968.50 million, reached on September 30, 2021.
Performance
NTLA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NTLA Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +42.5% | -100.0% | -33.1% |
| 3 y3 years | -74.8% | -100.0% | -82.7% |
| 5 y5 years | +143.0% | -100.0% | -38.1% |
NTLA Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -74.8% | +42.5% | -100.0% | at low | -82.6% | +58.2% |
| 5 y | 5-year | -74.8% | +143.0% | -100.0% | at low | -87.0% | +58.2% |
| alltime | all time | -74.8% | +361.9% | -100.0% | +100.0% | -87.0% | >+9999.0% |
NTLA Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $0.00(-100.0%) | $125.75M(-32.3%) |
| Dec 2024 | $185.75M(+42.5%) | $2.32M(-97.2%) | $185.75M(-35.9%) |
| Sep 2024 | - | $82.19M(+99.3%) | $289.91M(+27.8%) |
| Jun 2024 | - | $41.25M(-31.2%) | $226.82M(+20.6%) |
| Mar 2024 | - | $59.99M(-43.7%) | $188.09M(+44.3%) |
| Dec 2023 | $130.32M(-77.6%) | $106.48M(+457.4%) | $130.32M(-75.4%) |
| Sep 2023 | - | $19.10M(+659.2%) | $529.60M(-0.9%) |
| Jun 2023 | - | $2.52M(+13.3%) | $534.48M(-0.6%) |
| Mar 2023 | - | $2.22M(-99.6%) | $537.86M(-7.7%) |
| Dec 2022 | $582.96M(-20.9%) | $505.76M(+2009.4%) | $582.96M(+633.5%) |
| Sep 2022 | - | $23.98M(+306.7%) | $79.47M(-89.0%) |
| Jun 2022 | - | $5.89M(-87.5%) | $724.17M(-0.2%) |
| Mar 2022 | - | $47.32M(+1975.4%) | $725.41M(-1.5%) |
| Dec 2021 | $736.69M(+98.2%) | $2.28M(-99.7%) | $736.69M(-23.9%) |
| Sep 2021 | - | $668.68M(+9274.5%) | $968.50M(+222.4%) |
| Jun 2021 | - | $7.13M(-87.8%) | $300.42M(-29.4%) |
| Mar 2021 | - | $58.59M(-75.0%) | $425.51M(+14.5%) |
| Dec 2020 | $371.78M | $234.09M(>+9900.0%) | $371.78M(+136.4%) |
| Sep 2020 | - | $597.00K(-99.5%) | $157.25M(-22.6%) |
| Jun 2020 | - | $132.22M(+2618.4%) | $203.05M(+162.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $4.86M(-75.1%) | $77.30M(+1.1%) |
| Dec 2019 | $76.43M(+90.1%) | $19.56M(-57.8%) | $76.43M(-12.2%) |
| Sep 2019 | - | $46.40M(+617.0%) | $87.03M(+103.3%) |
| Jun 2019 | - | $6.47M(+61.8%) | $42.81M(+14.2%) |
| Mar 2019 | - | $4.00M(-86.7%) | $37.50M(-6.8%) |
| Dec 2018 | $40.22M(-71.9%) | $30.16M(+1283.6%) | $40.22M(-73.6%) |
| Sep 2018 | - | $2.18M(+88.7%) | $152.17M(+1.2%) |
| Jun 2018 | - | $1.16M(-82.8%) | $150.36M(+0.5%) |
| Mar 2018 | - | $6.72M(-95.3%) | $149.65M(+4.7%) |
| Dec 2017 | $142.98M(-14.5%) | $142.12M(>+9900.0%) | $142.98M(>+9900.0%) |
| Sep 2017 | - | $371.00K(-16.8%) | $1.13M(-202.3%) |
| Jun 2017 | - | $446.00K(+848.9%) | -$1.10M(-100.7%) |
| Mar 2017 | - | $47.00K(-82.0%) | $168.55M(+0.7%) |
| Dec 2016 | $167.30M(+138.0%) | $261.00K(-114.1%) | $167.30M(+0.4%) |
| Sep 2016 | - | -$1.85M(-101.1%) | $166.59M(-29.2%) |
| Jun 2016 | - | $170.09M(<-9900.0%) | $235.16M(+263.1%) |
| Mar 2016 | - | -$1.20M(+162.1%) | $64.77M(-7.9%) |
| Dec 2015 | $70.29M | -$456.00K(-100.7%) | $70.29M(-0.6%) |
| Sep 2015 | - | $66.72M(<-9900.0%) | $70.74M(+1656.3%) |
| Jun 2015 | - | -$300.00K(-106.9%) | $4.03M(-6.9%) |
| Mar 2015 | - | $4.33M | $4.33M |
FAQ
- What is Intellia Therapeutics, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual CFF year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly CFF year-on-year change?
- What is Intellia Therapeutics, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. TTM CFF year-on-year change?
What is Intellia Therapeutics, Inc. annual cash flow from financing activities?
The current annual CFF of NTLA is $185.75M
What is the all time high annual CFF for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual cash flow from financing activities is $736.69M
What is Intellia Therapeutics, Inc. annual CFF year-on-year change?
Over the past year, NTLA annual cash flow from financing activities has changed by +$55.42M (+42.53%)
What is Intellia Therapeutics, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of NTLA is $0.00
What is the all time high quarterly CFF for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly cash flow from financing activities is $668.68M
What is Intellia Therapeutics, Inc. quarterly CFF year-on-year change?
Over the past year, NTLA quarterly cash flow from financing activities has changed by -$59.99M (-100.00%)
What is Intellia Therapeutics, Inc. TTM cash flow from financing activities?
The current TTM CFF of NTLA is $125.75M
What is the all time high TTM CFF for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high TTM cash flow from financing activities is $968.50M
What is Intellia Therapeutics, Inc. TTM CFF year-on-year change?
Over the past year, NTLA TTM cash flow from financing activities has changed by -$62.34M (-33.14%)